Want to see GB:IHC full AI Analyst Report?
Top Page
Inspiration Healthcare
(LSE:IHC)
Select Model
Select Model
Rating:56Neutral
Price Target:
18.00 p
▼(-2.70% Downside)
Action:Reiterated
Date:09/18/26
The score is driven primarily by improving financial performance—especially the strong 2026 operating and free cash flow rebound—tempered by continued net losses and a weakened equity position. Technicals are modestly positive in the short term but still below longer-term trend levels. Valuation is a headwind because negative earnings (negative P/E) and no dividend yield reduce traditional valuation support.
Positive Factors
Cash generation rebound
The return to strong positive operating and free cash flow in 2026 improves the company’s ability to fund operations internally. If sustained, this cash generation can support investment in products, servicing capability and working capital while reducing reliance on external financing.
Negative Factors
Persistent net losses
Operating recovery has not yet translated into bottom-line profitability, leaving the company exposed to further cost pressure or weaker demand. Continued net losses can constrain reinvestment, weaken retained capital and make the current turnaround less durable than the operating result suggests.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash generation rebound
The return to strong positive operating and free cash flow in 2026 improves the company’s ability to fund operations internally. If sustained, this cash generation can support investment in products, servicing capability and working capital while reducing reliance on external financing.
Read all positive factors
Inspiration Healthcare (IHC) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£15.47M
Dividend Yield1.56%
Average Volume (3M)21.92K
Price to Earnings (P/E)―
Beta (1Y)-0.31
Revenue Growth0.88%
EPS Growth94.67%
CountryUK
Employees194
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding89,663,370
10 Day Avg. Volume36,432
30 Day Avg. Volume21,916
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)0.89
Price to Sales (P/S)0.29
P/FCF Ratio2.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)£42.53M
Inspiration Healthcare Business Overview & Revenue Model
Company Description
Inspiration Healthcare Group plc (IHC.L) is a global provider of advanced medical technology, catering to critical care, operating theatre, and home healthcare applications worldwide. The company offers a comprehensive range of products, with a st...
How the Company Makes Money
IHC makes money primarily by selling and distributing medical devices and related products to healthcare customers (typically hospitals and health systems). Revenue is generated from (1) product sales of medical equipment (including IHC-owned/cont...
Inspiration Healthcare Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
58
Neutral
Cash Flow
66
Positive
| Breakdown | TTM | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.60M | 47.55M | 38.25M | 37.63M | 41.23M | 41.05M |
| Gross Profit | 18.91M | 20.07M | 16.38M | 17.89M | 17.63M | 20.25M |
| EBITDA | 1.25M | 2.37M | -12.44M | -2.43M | 2.76M | 6.17M |
| Net Income | -608.00K | -1.04M | -14.97M | -6.03M | 272.00K | 4.23M |
Balance Sheet | ||||||
| Total Assets | 36.87M | 35.71M | 41.08M | 49.01M | 54.89M | 50.11M |
| Cash, Cash Equivalents and Short-Term Investments | 533.00K | 1.17M | 733.00K | 609.00K | 2.28M | 9.25M |
| Total Debt | 11.08M | 11.77M | 14.97M | 12.83M | 13.08M | 7.54M |
| Total Liabilities | 20.99M | 20.04M | 24.45M | 20.05M | 19.42M | 14.62M |
| Stockholders Equity | 15.88M | 15.67M | 16.64M | 28.97M | 35.47M | 35.49M |
Cash Flow | ||||||
| Free Cash Flow | 5.38M | 6.27M | -3.52M | 380.00K | -11.86M | -436.00K |
| Operating Cash Flow | 6.05M | 6.88M | -1.55M | 2.01M | -3.52M | 3.54M |
| Investing Cash Flow | -4.00M | -2.97M | -1.74M | -2.69M | -8.34M | -3.97M |
| Financing Cash Flow | -2.13M | -3.47M | 3.61M | -1.19M | 4.88M | -964.00K |
Inspiration Healthcare Technical Analysis
Negative
18.50
Price Trends
18.75
Negative
19.26
Negative
21.29
Negative
Market Momentum
-0.13
Positive
29.54
Positive
16.94
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:IHC, the sentiment is Negative. The current price of 18.5 is above the 20-day moving average (MA) of 18.49, below the 50-day MA of 18.75, and below the 200-day MA of 21.29, indicating a bearish trend. The MACD of -0.13 indicates Positive momentum. The RSI at 29.54 is Positive, neither overbought nor oversold. The STOCH value of 16.94 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:IHC.
Inspiration Healthcare Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £194.70M | 24.28 | 23.05% | 3.51% | 10.02% | 19.83% | |
70 Outperform | £4.67B | 51.61 | 8.40% | 2.28% | 1.94% | -43.71% | |
68 Neutral | £9.27B | 19.51 | 12.25% | 2.66% | 2.17% | 27.33% | |
67 Neutral | £611.34M | 166.18 | 1.44% | 1.66% | 6.05% | -60.00% | |
56 Neutral | £15.47M | -25.37 | -3.85% | 1.56% | 0.88% | 94.67% | |
55 Neutral | £3.73M | -4.00 | -15.47% | ― | -3.68% | 20.00% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
GB:IHC
Inspiration Healthcare
17.25
-3.00
-14.81%
GB:AMS
Advanced Medical Solutions
282.50
67.49
31.39%
GB:CTEC
ConvaTec
244.40
11.17
4.79%
GB:SUN
Surgical Innovations
0.40
-0.18
-31.03%
GB:TSTL
Tristel
405.00
58.67
16.94%
GB:SN
Smith & Nephew
1,107.50
-251.88
-18.53%
Inspiration Healthcare Corporate Events
Business Operations and StrategyFinancial Disclosures
Inspiration Healthcare sets 27 October date for interim results and investor briefings
Positive
Oct 9, 2026
Inspiration Healthcare Group plc will publish its unaudited interim results for the six months ended 31 July 2026 on 27 October 2026, underscoring a key reporting milestone for the AIM-quoted medical technology firm. The company is pairing the rel...
Business Operations and StrategyFinancial Disclosures
Inspiration Healthcare posts strong underlying growth as neonatal portfolio drives outlook ahead of forecasts
Positive
Sep 8, 2026
Inspiration Healthcare reported revenue of £22.0 million for the six months to 31 July 2026, down from £24.0 million a year earlier due to the absence of £6.5 million of one-off export contracts booked in the prior period. Adjusted ...
Business Operations and StrategyExecutive/Board Changes
Inspiration Healthcare grants performance-linked share options to top executives
Positive
Aug 7, 2026
Inspiration Healthcare Group has granted 2,759,141 nil-cost share options under its Long-Term Incentive Plan, including substantial awards to chief executive Raffi Stepanian and chief financial officer Alan Olby. The grants comprise both performan...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.